Abstract: Multi subunit protein modules are provided. Accordingly, there is provided a multi subunit protein module comprising at least three cell membrane polypeptides each comprising an amino acid sequence of an Fc receptor common gamma chain (FcRgamma), said amino acid sequence is capable of transmitting an activating signal; wherein at least one but not all of said at least three polypeptides comprises an extracellular binding domain capable of binding a target that is presented on a cell surface of a target cell of an immune cell, such that upon binding of said extracellular binding domain to said target said activating signal is transmitted in an immune cell expressing said multi subunit protein module. Also provided are cells expressing the multi subunit protein modules and uses thereof.
Type:
Application
Filed:
December 21, 2022
Publication date:
October 26, 2023
Applicant:
Ramot at Tel-Aviv University Ltd.
Inventors:
Yaron CARMI, Peleg RIDER, Diana RASOULOUNIRIANA, Lior TAL
Abstract: The present invention provides pharmaceutical compositions comprising membrane vesicles, including extracellular vesicles including those referred to as exosomes, loaded with an exogenous Phosphatase and tensin homolog (PTEN) inhibitor. Methods of treating neurological diseases, disorders or conditions using the extracellular vesicles are provided. Isolated extracellular vesicles loaded with an exogenous Phosphatase and tensin homolog (PTEN) inhibitor are provided as well.
Type:
Application
Filed:
March 31, 2023
Publication date:
October 19, 2023
Applicants:
Technion Research and Development Foundation Limited, Ramot At Tel-Aviv University Ltd.
Inventors:
Shulamit Levenberg, Shaowei Guo, Daniel Offen, Nisim Perets
Abstract: A formulation includes an active agent, a thickening/solidifying agent, and an antioxidant. The active agent is 9-cis-?-carotene (9CBC) or a derivative thereof of the following formula: where R2 is H or methyl; X is optionally substituted with one or more methyl groups; n is an integer of 0-16; and the asterisk represents the point of attachment to the cyclohexene ring.
Type:
Grant
Filed:
October 11, 2021
Date of Patent:
October 3, 2023
Assignee:
Ramot at Tel-Aviv University Ltd.
Inventors:
Ehud Gazit, Ludmila Buzhansky, Michael Ioffe, Alon Sayer
Abstract: A method of treating glioblastoma in a subject in need thereof is disclosed. The method comprises administering to the subject a therapeutically effective amount of an agent that specifically decreases an amount and/or activity of P-selectin.
Abstract: Some embodiments are directed to a technique having an off-axis interferometric geometry that is capable of spatially multiplexing at least six complex wavefronts, while using the same number of camera pixels typically needed for a single off-axis hologram encoding a single complex wavefront. Each of the at least six parallel complex wavefronts is encoded into an off-axis hologram with a different fringe orientation, and all complex wavefronts can be fully reconstructed. This technique is especially useful for highly dynamic samples, as it allows the acquisition of at least six complex wavefronts simultaneously, optimizing the amount of information that can be acquired in a single camera exposure. The off-axis multiplexing holographic system of some embodiments provide an off-axis holography modality that is more camera spatial bandwidth efficient than on-axis holography.
Abstract: A spin-selective conduction structure comprises a crystal having a monolayer of metal atoms between two layers of chiral organic molecules. Each metal atom is coupled to two chiral organic molecules, one at each layer, wherein a chirality of organic molecules in one of the two layers is the same as a chirality of organic molecules in another one of the two layers.
Type:
Application
Filed:
March 8, 2021
Publication date:
September 21, 2023
Applicants:
Ramot at Tel-Aviv University Ltd., Yeda Research and Development Co. Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Inventors:
Ehud GAZIT, Ron NAAMAN, Yossi PALTIEL, Shira YOCHELIS, Sharon GILEAD, Pandeeswar MAKAM, Amit Kumar MONDAL, Noam BROWN, Naama GOREN
Abstract: Polymeric conjugates comprising a polymeric matrix having associated therewith an agent that down-regulates an activity or expression of a polypeptide associated with onset or progression of melanoma, and optionally and preferably, an additional agent that acts in synergy with said agent, are provided. Synthetic methodologies for preparing these conjugates and uses thereof in treating melanoma and other cancerous diseases are also provided.
Type:
Application
Filed:
April 28, 2023
Publication date:
September 7, 2023
Applicant:
Ramot at Tel-Aviv University Ltd.
Inventors:
Ronit SATCHI-FAINARO, Evgeni PISAREVSKY, Anat ELDAR-BOOCK, Dikla BEN-SHUSHAN, Yana EPSHTEIN, Anna SCOMPARIN
Abstract: The present invention provides polypeptides derived from the coronaviruses (CoVs) Spike protein (S) characterized by high affinity and specificity the S receptor and its neutralizing antibodies. The invention further provides compositions and vaccines, and vaccine-based therapies targeting CoVs, and SARS and MERS viruses in particular.
Abstract: Provided herein is an insert chip and a cell culture system including the same, adapted for culturing a plurality of cell populations under various flow patterns.
Type:
Application
Filed:
May 9, 2023
Publication date:
August 31, 2023
Applicant:
Ramot at Tel-Aviv University Ltd.
Inventors:
Ben Meir MAOZ, Rossana RAUTI, Adi ESS, Mark Dan KIRI
Abstract: Repair devices and methods allow better contact between two tissues, such as tendon and bone for better healing process. The repair device is used for re-attaching and securing a torn tissue in place or realigning torn edges back together, or connecting any two tissues. The device includes a tissue attachment, a clamp and a binder and/or an anchor.
Type:
Grant
Filed:
November 15, 2017
Date of Patent:
August 22, 2023
Assignees:
Ramot at Tel-Aviv University Ltd., The Medical Research, Infrastructure, and Health Services Fund of the Tel-Aviv Medical Center
Inventors:
Roy Gigi, Mickey Scheinowitz, Noaa Reisman, Itzhak Mallayev, Roman Ziv, Sivan Goldin
Abstract: An imaging device is presented for use in an imaging system capable of improving the image quality. The imaging device has one or more optical systems defining an effective aperture of the imaging device. The imaging device comprises a lens system having an algebraic representation matrix of a diagonalized form defining a first Condition Number, and a phase encoder utility adapted to effect a second Condition Number of an algebraic representation matrix of the imaging device, smaller than said first Condition Number of the lens system.
Abstract: In a system for converting digital data into a modulated optical signal, an electrically controllable device, including a modulator having one or more actuating electrodes, provides an analog-modulated optical signal that is modulated in response to output data bits of a digital-to-digital mapping. A digital-to-digital conversion provides the mapping of input data words to the output data bits. The mapping enables adjustments to correct for non-linearities and other undesirable characteristics, thereby improving signal quality.
Abstract: Methods of designing a polynucleotide sequence for expressing a polypeptide-of-interest in a cell are provided. Also provided are artificial transcript sequences generated according to the present teachings. Further provided are methods of estimating the adaptiveness of a transcript sequence encoding a polypeptide-of-interest to a gene expression machinery in a cell.
Abstract: A method of diagnosing lung cancer in a subject-in-need thereof is provided. The method comprises: (a) providing a biological sample of the subject which comprises peripheral blood mononuclear cells (PBMCs); (b) in vitro contacting the PBMCs with a stimulant selected from the group consisting of the stimulants listed in Tables 3 and 4; and (c) measuring metabolic activity of the PBMCs having been contacted according to (b), wherein a statistically significant change in the metabolic activity of the PBMCs as compared to a control sample is indicative of lung cancer.
Type:
Application
Filed:
January 27, 2023
Publication date:
July 20, 2023
Applicants:
Savicell Diagnostic Ltd., Ramot at Tel-Aviv University Ltd.
Inventors:
Giora DAVIDOVITS, Fernando PATOLSKY, David Eyal DAVIDOVITS, Irit ARBEL, Shoval TIRMAN, Aviv LUTATY, Tali SCIENMANN, Reuven TIROSH, Hagit PERETZ-SOROKA
Abstract: Methods of detecting methylated CpG are provided. Accordingly, there is provided a method of determining CpG methylation status in a DNA sample, the method comprising: (a) subjecting the DNA sample to bisulfite conversion; (b) amplifying said DNA sample following said (a) to obtain an amplified DNA sample; (c) labeling CpG sites in said amplified DNA sample with a label to obtain a labeled DNA sample; (d) contacting said labeled DNA sample on an array comprising a plurality of probes for said DNA under conditions which allow specific hybridization between said plurality of probes and said DNA; and (e)detecting said hybridization, wherein an amount of said label is indicative of the CpG methylation status in said DNA sample.
Abstract: An imaging device is presented for use in an imaging system capable of improving the image quality. The imaging device has one or more optical systems defining an effective aperture of the imaging device. The imaging device comprises a lens system having an algebraic representation matrix of a diagonalized form defining a first Condition Number, and a phase encoder utility adapted to effect a second Condition Number of an algebraic representation matrix of the imaging device, smaller than said first Condition Number of the lens system.
Abstract: There is provided a computer implemented method of automatic segmentation of three dimensional (3D) anatomical region of interest(s) (ROI) that includes predefined anatomical structure(s) of a target individual, comprising: receiving 3D images of a target individual, each including the predefined anatomical structure(s), each 3D image is based on a different respective imaging modality. In one implementation, each respective 3D image is inputted into a respective processing component of a multi-modal neural network, wherein each processing component independently computes a respective intermediate, and the intermediate outputs are inputted into a common last convolutional layer(s) for computing the indication of segmented 3D ROI(s). In another implementation, each respective 3D image is inputted into a respective encoding-contracting component a multi-modal neural network, wherein each encoding-contracting component independently computes a respective intermediate output.
Type:
Grant
Filed:
September 28, 2021
Date of Patent:
July 11, 2023
Assignees:
Ramot at Tel-Aviv University Ltd., Tel HaShomer Medical Research Infrastructure and Services Ltd.
Inventors:
Yitzhak Avital, Nahum Kiryati, Eli Konen, Arnaldo Mayer
Abstract: A cloaking and/or deception system comprises: a structure having a plurality of resonators characterized by a controllable resonance frequency, wherein the resonators are arranged to collectively ensure that variation of the resonance frequency over a predetermined range of resonance frequencies generates a phase shift between the an electromagnetic wave incident on the structure and an electromagnetic wave scattered off the structure; and a controller configured for controlling the resonance frequency to provide a time-varying resonance frequency characterized by a temporal function which comprises a linear time-dependence.
Type:
Application
Filed:
April 16, 2021
Publication date:
June 29, 2023
Applicant:
Ramot at Tel-Aviv University Ltd.
Inventors:
Pavel GINZBURG, Vitali KOZLOV, Dmytro VOVCHUK